Clinical Trial

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.
Trial Details
NCT Number NCT06836557
Lead Sponsor Vanda Pharmaceuticals
Conditions Idiopathic Gastroparesis, Diabetic Gastroparesis, Gastroparesis
Enrollment 100 participants
Start Date 2024-01-09
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-20